Side-by-side comparison of AI visibility scores, market position, and capabilities
International tobacco leader transformed by IQOS heated tobacco (32.4M users) and ZYN nicotine pouches; $37.9B FY2024 revenue; 65%+ smoke-free revenue target; $16B Swedish Match acquisition 2022.
Philip Morris International (PMI) is the world's largest international tobacco and smoke-free products company, spun off from Altria Group in 2008 and headquartered in Stamford, Connecticut, trading on NYSE (PM). PMI sells products in approximately 180 markets outside the United States and generated approximately $37.9 billion in net revenues for FY2024 under CEO Jacek Olczak, who has accelerated the company's transformation toward a smoke-free future. PMI's strategic pivot is anchored by IQOS—a heated tobacco system that heats tobacco sticks (HEETS/Terea) to generate nicotine-containing aerosol without combustion—which has achieved category-creating success in Japan, Italy, Germany, and Eastern Europe with approximately 32.4 million users globally as of 2024.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.